Please enable JavaScript to continue using this application.

Compare $TLSI vs $UPB | Chartloom

Compare

$TLSI vs $UPB

TriSalus Life Sciences Inc · Upstream Bio Inc

TLSI

TriSalus Life Sciences Inc

UPB

Upstream Bio Inc

Compare $TLSI vs $UPB

Comparing TriSalus Life Sciences Inc and Upstream Bio Inc

TLSITriSalus Life Sciences Inc

UPBUpstream Bio Inc

TLSITriSalus Life Sciences Inc

Market cap

$249M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.61x

Rev growth (TTM)

25.2%

YTD performance

-33.4%

52W performance

-16.3%

FCF yield

-9.3%

UPBUpstream Bio Inc

Market cap

$256M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

168.72x

Rev growth (TTM)

16.0%

YTD performance

-82.6%

52W performance

-75.2%

FCF yield

-53.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

TLSI

UPB

Detailed metrics comparison

TLSI

TriSalus Life Sciences Inc

UPB

Upstream Bio Inc

Market Cap

TLSI$249M

UPB$256M

Enterprise Value

TLSI$236M

UPB$176M

Price

TLSI$4.06

UPB$4.70

P/E Ratio

TLSIN/A

UPBN/A

P/S Ratio

TLSI5.53x

UPB80.99x

EV/Sales

TLSI5.24x

UPB55.85x

EV/EBITDA

TLSI0.00x

UPB0.00x

P/B Ratio

TLSI40.61x

UPB1.02x

P/FCF Ratio

TLSIN/A

UPBN/A

EV/FCF

TLSI-10.14x

UPB-1.29x

PEG Ratio

TLSIN/A

UPBN/A

Forward P/E (NTM)

TLSIN/A

UPBN/A

Forward P/S (NTM)

TLSI3.61x

UPB168.72x

Revenue (TTM)

TLSI$45M

UPB$3M

Revenue Growth (YoY)

TLSI25.2%

UPB16.0%

Forward Rev Growth

TLSI40.1%

UPB-48.7%

Gross Margin (TTM)

TLSI85.8%

UPB0.0%

Operating Margin (TTM)

TLSI0.0%

UPB0.0%

EBITDA Margin (TTM)

TLSI-66.4%

UPB-5376.3%

Net Margin (TTM)

TLSI-130.2%

UPB-4955.7%

FCF Margin (TTM)

TLSI-51.6%

UPB-4321.2%

Net Income (TTM)

TLSI$-59M

UPB$-157M

FCF (TTM)

TLSI$-23M

UPB$-136M

EPS (TTM)

TLSI-$1.01

UPB-$2.87

ROE (TTM)

TLSI-7902.0%

UPB-4840.0%

ROA (TTM)

TLSI-5499.0%

UPB-4657.0%

ROIC (TTM)

TLSI-1789.0%

UPB-4840.0%

Cash

TLSI$46M

UPB$79M

Debt

TLSI$33M

UPB$0

Net Cash/Debt

TLSI$13M

UPB$79M

Current Ratio (TTM)

TLSI5.35x

UPB27.99x

Quick Ratio (TTM)

TLSI4.72x

UPB27.84x

Debt/Equity (TTM)

TLSI5.05x

UPB0.00x

Debt/Assets (TTM)

TLSI0.0%

UPB0.0%

Interest Coverage (TTM)

TLSIN/A

UPBN/A

Net Debt/EBITDA (TTM)

TLSI0.00x

UPB0.00x

Beta

TLSI0.46

UPB2.30

52W Performance

TLSI-16.3%

UPB-75.2%

YTD Performance

TLSI-33.4%

UPB-82.6%

% from 52W High

TLSI-48.9%

UPB-86.0%

% from 52W Low

TLSI84.5%

UPB7.7%

Asset Turnover (TTM)

TLSI0.88x

UPB0.01x

FCF Yield (TTM)

TLSI-9.3%

UPB-53.4%

Earnings Yield (TTM)

TLSI-23.5%

UPB-61.2%

Dividend Yield (TTM)

TLSIN/A

UPBN/A

Rule of 40

TLSI-26.4

UPB-4,305.2

EV/GP/RG

TLSI0.11

UPBN/A

Ticker research

View TLSI research View UPB research

Metric	TLSI TriSalus Life Sciences Inc	UPB Upstream Bio Inc
Market & Valuation
Market Cap	$249M	$256M
Enterprise Value	$236M	$176M
Price	$4.06	$4.70
P/E Ratio	N/A	N/A
P/S Ratio	5.53x	80.99x
EV/Sales	5.24x	55.85x
EV/EBITDA	0.00x	0.00x
P/B Ratio	40.61x	1.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.14x	-1.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.61x	168.72x
Revenue & Growth
Revenue (TTM)	$45M	$3M
Revenue Growth (YoY)	25.2%	16.0%
Forward Rev Growth	40.1%	-48.7%
Profitability
Gross Margin (TTM)	85.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-66.4%	-5376.3%
Net Margin (TTM)	-130.2%	-4955.7%
FCF Margin (TTM)	-51.6%	-4321.2%
Net Income (TTM)	$-59M	$-157M
FCF (TTM)	$-23M	$-136M
EPS (TTM)	-$1.01	-$2.87
ROE (TTM)	-7902.0%	-4840.0%
ROA (TTM)	-5499.0%	-4657.0%
ROIC (TTM)	-1789.0%	-4840.0%
Financial Health
Cash	$46M	$79M
Debt	$33M	$0
Net Cash/Debt	$13M	$79M
Current Ratio (TTM)	5.35x	27.99x
Quick Ratio (TTM)	4.72x	27.84x
Debt/Equity (TTM)	5.05x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.46	2.30
52W Performance	-16.3%	-75.2%
YTD Performance	-33.4%	-82.6%
% from 52W High	-48.9%	-86.0%
% from 52W Low	84.5%	7.7%
Efficiency & Yields
Asset Turnover (TTM)	0.88x	0.01x
FCF Yield (TTM)	-9.3%	-53.4%
Earnings Yield (TTM)	-23.5%	-61.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-26.4	-4,305.2
EV/GP/RG	0.11	N/A
Ticker research	View TLSI research	View UPB research

Valuation

P/S Ratio

TLSI

5.53x

UPB

80.99x

EV/FCF

TLSI

-10.14x

UPB

-1.29x

Growth & revenue

Revenue Growth TTM

TLSI

25.2%

UPB

16.0%

Forward Revenue Growth

TLSI

40.1%

UPB

-48.7%

Profitability & performance

Gross Margin

TLSI

85.8%

UPB

0.0%

ROE

UPB

-4840.0%

TLSI

-7902.0%

FCF Yield %

TLSI

-9.3%

UPB

-53.4%

52-Week Performance

TLSI

-16.3%

UPB

-75.2%

Detailed metrics comparison

TLSI

TriSalus Life Sciences Inc

UPB

Upstream Bio Inc

Market Cap

TLSI$249M

UPB$256M

Enterprise Value

TLSI$236M

UPB$176M

Price

TLSI$4.06

UPB$4.70

P/E Ratio

TLSIN/A

UPBN/A

P/S Ratio

TLSI5.53x

UPB80.99x

EV/Sales

TLSI5.24x

UPB55.85x

EV/EBITDA

TLSI0.00x

UPB0.00x

P/B Ratio

TLSI40.61x

UPB1.02x

P/FCF Ratio

TLSIN/A

UPBN/A

EV/FCF

TLSI-10.14x

UPB-1.29x

PEG Ratio

TLSIN/A

UPBN/A

Forward P/E (NTM)

TLSIN/A

UPBN/A

Forward P/S (NTM)

TLSI3.61x

UPB168.72x

Revenue (TTM)

TLSI$45M

UPB$3M

Revenue Growth (YoY)

TLSI25.2%

UPB16.0%

Forward Rev Growth

TLSI40.1%

UPB-48.7%

Gross Margin (TTM)

TLSI85.8%

UPB0.0%

Operating Margin (TTM)

TLSI0.0%

UPB0.0%

EBITDA Margin (TTM)

TLSI-66.4%

UPB-5376.3%

Net Margin (TTM)

TLSI-130.2%

UPB-4955.7%

FCF Margin (TTM)

TLSI-51.6%

UPB-4321.2%

Net Income (TTM)

TLSI$-59M

UPB$-157M

FCF (TTM)

TLSI$-23M

UPB$-136M

EPS (TTM)

TLSI-$1.01

UPB-$2.87

ROE (TTM)

TLSI-7902.0%

UPB-4840.0%

ROA (TTM)

TLSI-5499.0%

UPB-4657.0%

ROIC (TTM)

TLSI-1789.0%

UPB-4840.0%

Cash

TLSI$46M

UPB$79M

Debt

TLSI$33M

UPB$0

Net Cash/Debt

TLSI$13M

UPB$79M

Current Ratio (TTM)

TLSI5.35x

UPB27.99x

Quick Ratio (TTM)

TLSI4.72x

UPB27.84x

Debt/Equity (TTM)

TLSI5.05x

UPB0.00x

Debt/Assets (TTM)

TLSI0.0%

UPB0.0%

Interest Coverage (TTM)

TLSIN/A

UPBN/A

Net Debt/EBITDA (TTM)

TLSI0.00x

UPB0.00x

Beta

TLSI0.46

UPB2.30

52W Performance

TLSI-16.3%

UPB-75.2%

YTD Performance

TLSI-33.4%

UPB-82.6%

% from 52W High

TLSI-48.9%

UPB-86.0%

% from 52W Low

TLSI84.5%

UPB7.7%

Asset Turnover (TTM)

TLSI0.88x

UPB0.01x

FCF Yield (TTM)

TLSI-9.3%

UPB-53.4%

Earnings Yield (TTM)

TLSI-23.5%

UPB-61.2%

Dividend Yield (TTM)

TLSIN/A

UPBN/A

Rule of 40

TLSI-26.4

UPB-4,305.2

EV/GP/RG

TLSI0.11

UPBN/A

Ticker research

View TLSI research View UPB research

Metric	TLSI TriSalus Life Sciences Inc	UPB Upstream Bio Inc
Market & Valuation
Market Cap	$249M	$256M
Enterprise Value	$236M	$176M
Price	$4.06	$4.70
P/E Ratio	N/A	N/A
P/S Ratio	5.53x	80.99x
EV/Sales	5.24x	55.85x
EV/EBITDA	0.00x	0.00x
P/B Ratio	40.61x	1.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.14x	-1.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.61x	168.72x
Revenue & Growth
Revenue (TTM)	$45M	$3M
Revenue Growth (YoY)	25.2%	16.0%
Forward Rev Growth	40.1%	-48.7%
Profitability
Gross Margin (TTM)	85.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-66.4%	-5376.3%
Net Margin (TTM)	-130.2%	-4955.7%
FCF Margin (TTM)	-51.6%	-4321.2%
Net Income (TTM)	$-59M	$-157M
FCF (TTM)	$-23M	$-136M
EPS (TTM)	-$1.01	-$2.87
ROE (TTM)	-7902.0%	-4840.0%
ROA (TTM)	-5499.0%	-4657.0%
ROIC (TTM)	-1789.0%	-4840.0%
Financial Health
Cash	$46M	$79M
Debt	$33M	$0
Net Cash/Debt	$13M	$79M
Current Ratio (TTM)	5.35x	27.99x
Quick Ratio (TTM)	4.72x	27.84x
Debt/Equity (TTM)	5.05x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.46	2.30
52W Performance	-16.3%	-75.2%
YTD Performance	-33.4%	-82.6%
% from 52W High	-48.9%	-86.0%
% from 52W Low	84.5%	7.7%
Efficiency & Yields
Asset Turnover (TTM)	0.88x	0.01x
FCF Yield (TTM)	-9.3%	-53.4%
Earnings Yield (TTM)	-23.5%	-61.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-26.4	-4,305.2
EV/GP/RG	0.11	N/A
Ticker research	View TLSI research	View UPB research